Vascular and hepatic impact of short-term intermittent hypoxia in a mouse model of metabolic syndrome

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Trzepizur, Wojciech ^a,b   Gaceb, Abderahim ^a   Arnaud, Claire ^c   Ribuot, Christophe ^c   Levy, Patrick ^c,d   Martinez, M Carmen ^a   Gagnadoux, Frédéric ^a,b   Andriantsitohaina, Ramaroson ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c University Grenoble Alpes   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CYTOCHROME C OXIDASE; GLUCOSE; INSULIN; LACTATE DEHYDROGENASE; LEPTIN; LIPID; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; EPIDIDYMIS FAT; EX VIVO STUDY; FATTY LIVER; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INTERMITTENT HYPOXIA THERAPY; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIVER METABOLISM; LIVER MITOCHONDRION; MALE; METABOLIC SYNDROME X; MITOCHONDRIAL RESPIRATION; MOUSE; MYOGRAPHY; NONHUMAN; SUPPLEMENTATION; THERAPY EFFECT; VASCULAR RING; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; COMPLICATION; DISEASE MODEL; GLYCOLYSIS; HYPOXIA; LIPID METABOLISM; LIVER; METABOLISM; PATHOPHYSIOLOGY; SLEEP DISORDERED BREATHING; VASCULAR ENDOTHELIUM;

ANIMALIA; MUS;

ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GLYCOLYSIS; HYPOXIA; INSULIN; LEPTIN; LIPID METABOLISM; LIVER; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MITOCHONDRIA, LIVER; NITRIC OXIDE; SLEEP APNEA, OBSTRUCTIVE;

EID: 84930645138     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124637     Document Type: Article

References (59)

1. Allende-Vigo MZ (2010) Pathophysiologic mechanisms linking adipose tissue and cardiometabolic risk. Endocr Pract 16: 692-698. doi: 10.4158/EP09340.RA PMID: 20439246
2. Kopelman PG (2000) Obesity as a medical problem. Nature 404: 635-643. PMID: 10766250
3. Perlemuter G, Bigorgne A, Cassard-Doulcier AM, Naveau S (2007) Nonalcoholic fatty liver disease: from pathogenesis to patient care. Nat Clin Pract Endocrinol Metab 3: 458-469. PMID: 17515890
4. Thakur ML, Sharma S, Kumar A, Bhatt SP, Luthra K, Guleria R et al. (2012) Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis 223: 507-511. doi: 10.1016/j.atherosclerosis.2012.06.005 PMID: 22748277
5. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E et al. (2005) Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 42: 473-480. PMID: 15981216
6. Drager LF, Lopes HF, Maki-Nunes C, Trombetta IC, Toschi-Dias E, Alves MJ et al. (2010) The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 5: e12065. doi: 10.1371/journal.pone.0012065 PMID: 20711453
7. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365: 1046-1053. PMID: 15781100
8. Minville C, Hilleret MN, Tamisier R, Aron-Wisnewsky J, Clement K, Trocme C et al. (2014) Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea. Chest 145: 525-533. doi: 10.1378/chest.13-0938 PMID: 24264333
9. Dematteis M, Godin-Ribuot D, Arnaud C, Ribuot C, Stanke-Labesque F, Pepin JL et al. (2009) Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding the human disease. Ilar J 50: 262-81. PMID: 19506313
10. Priou P, Le Vaillant M, Meslier N, Chollet S, Masson P, Humeau MP et al. (2012) Independent association between obstructive sleep apnea severity and glycated hemoglobin in adults without diabetes. Diabetes Care 35: 1902-1906. PMID: 22688546
11. Trzepizur W, Le Vaillant M, Meslier N, Pigeanne T, Masson P, Humeau MP et al. (2013) Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia. Chest 143: 1584-1589. doi: 10.1378/chest.12-1652 PMID: 23699812
12. Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT et al. (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 6: e1000132. doi: 10.1371/journal.pmed.1000132 PMID: 19688045
13. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, et O'Doherty RM al. (2007) Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175: 851-857. PMID: 17272786
14. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846. PMID: 17167471
15. Drager LF, Li J, Reinke C, Bevans-Fonti S, Jun JC, Polotsky VY (2011) Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) 19:2167-2174. doi: 10.1038/oby.2011.240 PMID: 21799478
16. Delarue J, Magnan C (2007) Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10:142-148. PMID: 17285001
17. Berlanga A, Guiu-Jurado E, Porras JA, Auguet T (2014) Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol 7:221-239. doi: 10.2147/CEG.S62831 PMID: 25045276
18. Manukhina EB, Jasti D, Vanin AF, Downey HF (2011) Intermittent hypoxia conditioning prevents endothelial dysfunction and improves nitric oxide storage in spontaneously hypertensive rats. Exp Biol Med (Maywood) 236(7): 867-873. doi: 10.1258/ebm.2011.011023 PMID: 21652603
19. Milano G, Abruzzo PM, Bolotta A, Marini M, Terraneo L, Ravara B et al.(2013) Impact of the phosphatidylinositide 3-kinase signaling pathway on the cardioprotection induced by intermittent hypoxia. PLoS One 8: e76659. doi: 10.1371/journal.pone.0076659 PMID: 24124584
20. Almendros I, Wang Y, Gozal D (2014) The Polymorphic and Contradictory Aspects of Intermittent Hypoxia. Am J Physiol Lung Cell Mol Physiol 307: 129-140.
21. Mingorance C, Duluc L, Chalopin M, Simard G, Ducluzeau PH, Herrera MD et al. (2012) Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity. PLoS One 7:e34268. doi: 10.1371/journal.pone.0034268 PMID: 22457831
22. Arnaud C, Beguin PC, Lantuejoul S, Pepin JL, Guillermet C, Pelli G et al. (2011) The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition. Am J Respir Crit Care Med 184: 724-731. doi: 10.1164/rccm.201012-2033OC PMID: 21680945
23. Xu H, Wilcox D, Nguyen P, Voorbach M, Suhar T, Morgan SJ et al. (2006) Hepatic knockdown of mitochondrial GPAT1 in ob/ob mice improves metabolic profile. Biochem Biophys Res Commun 349:439-448. PMID: 16935266
24. Malagat MLT DG, Mazat JP (1999). Enzymatic and polarographic measurements of the respiratory chain complexes. In: Mitochondrial Diseases. Berlin
25. Hutter E, Renner K, Pfister G, Stockl P, Jansen-Durr P, Gnaiger E (2004) Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. Biochem J 380: 919-928. PMID: 15018610
26. Martin S, Tesse A, Hugel B, Martinez MC, Morel O, Freyssinet JM et al. (2004) Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation 109: 1653-1659. PMID: 15023873
27. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G et al. (2008) Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 173:1210-1219. doi: 10.2353/ajpath.2008.080228 PMID: 18772329
28. Hochachka PW, Stanley C, Merkt J, Sumar-Kalinowski J (1983) Metabolic meaning of elevated levels of oxidative enzymes in high altitude adapted animals: an interpretive hypothesis. Respir Physiol 52: 303-313. PMID: 6612104
29. Grattagliano I, de Bari O, Bernardo TC, Oliveira PJ, Wang DQ, Portincasa P (2012) Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation. Clin Biochem 45:610-618. doi: 10.1016/j.clinbiochem.2012.03.024 PMID: 22484459
30. Vial G, Dubouchaud H, Couturier K, Cottet-Rousselle C, Taleux N, Athias A et al. (2011) Effects of a high-fat diet on energy metabolism and ROS production in rat liver. J Hepatol 54:348-356. doi: 10.1016/j.jhep.2010.06.044 PMID: 21109325
31. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS et al. (2007) Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 293: 871-877.
32. Reinke C, Bevans-Fonti S, Drager LF, Shin MK, Polotsky VY (2011) Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J Appl Physiol (1985) 111: 881-890. doi: 10.1152/japplphysiol.00492.2011 PMID: 21737828
33. Jackman KA, Zhou P, Faraco G, Peixoto PM, Coleman C, Voss HU et al. (2014) Dichotomous effects of chronic intermittent hypoxia on focal cerebral ischemic injury. Stroke 45:1460-1467. doi: 10.1161/STROKEAHA.114.004816 PMID: 24713530
34. Wang ZH, Cai XL, Wu L, Yu Z, Liu JL, Zhou ZN et al. (2012) Mitochondrial energy metabolism plays a critical role in the cardioprotection afforded by intermittent hypobaric hypoxia. Exp Physiol 97: 1105-1118. PMID: 22562809
35. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM et al. (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 275: 25130-25138. PMID: 10833514
36. Guzy RD, Mack MM, Schumacker PT (2007) Mitochondrial complex III is required for hypoxia-induced ROS production and gene transcription in yeast. Antioxid Redox Signal 9: 1317-1328. PMID: 17627464
37. Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660-2667 PMID: 16246965
38. Ketonen J, Pilvi T, Mervaala E (2010) Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57Bl/6 mice. Heart Vessels 25: 254-262. doi: 10.1007/s00380-009-1182-x PMID: 20512454
39. Phillips SA, Olson EB, Morgan BJ, Lombard JH (2004) Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286: 388-393.
40. Marcus NJ, Philippi NR, Bird CE, Li YL, Schultz HD, Morgan BJ (2012) Effect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction. Respir Physiol Neurobiol 183:67-74. doi: 10.1016/j.resp.2012.05.025 PMID: 22728949
41. Wang B, Yan B, Song D, Ye X, Liu SF (2013) Chronic intermittent hypoxia down-regulates endothelial nitric oxide synthase expression by an NF-kappaB-dependent mechanism. Sleep Med 14: 165-171. doi: 10.1016/j.sleep.2012.10.020 PMID: 23266106
42. Dematteis M, Julien C, Guillermet C, Sturm N, Lantuejoul S, Lantuejoul S et al. (2008) Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 177: 227-235. PMID: 17962641
43. Badran M, Golbidi S, Devlin A, Ayas N, Laher I (2014) Chronic intermittent hypoxia causes endothelial dysfunction in a mouse model of diet-induced obesity. Sleep Med 15:596-602. doi: 10.1016/j.sleep.2014.01.013 PMID: 24767726
44. Wang Z, Si LY. (2013) Hypoxia-inducible factor-1alpha and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats. Ups J Med Sci 118: 65-74. doi: 10.3109/03009734.2013.766914 PMID: 23441597
45. Bertuglia S (2008) Intermittent hypoxia modulates nitric oxide-dependent vasodilation and capillary perfusion during ischemia-reperfusion-induced damage. Am J Physiol Heart Circ Physiol 294: 1914-1922.
46. Yokoe T, Alonso LC, Romano LC, Rosa TC, O'Doherty RM, Garcia-Ocana A et al. (2008) Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol 586:899-911. PMID: 18033815
47. Wang N, Khan SA, Prabhakar NR, Nanduri J (2013) Impairment of pancreatic beta-cell function by chronic intermittent hypoxia. Exp Physiol 98:1376-1385. doi: 10.1113/expphysiol.2013.072454 PMID: 23709585
48. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T et al. (2000) Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101: 676-681. PMID: 10673261
49. Manrique C, Lastra G, Sowers JR (2014) New insights into insulin action and resistance in the vasculature. Ann N Y Acad Sci 1311: 138-150. doi: 10.1111/nyas.12395 PMID: 24650277
50. Muniyappa R, Montagnani M, Koh KK, Quon MJ (2007) Cardiovascular actions of insulin. Endocr Rev 28: 463-491. PMID: 17525361
51. Montagnani M, Ravichandran LV, Chen H, Esposito DL, Quon MJ (2002) Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol Endocrinol 16: 1931-1942. PMID: 12145346
52. Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstone ML, Mundhekar AN et al. (2002) Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 277: 1794-1799. PMID: 11707433
53. Olea E, Agapito MT, Gallego-Martin T, Rocher A, Gomez-Nino A, Obeso A et al. (2014) Intermittent hypoxia and diet-induced obesity: Effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure. J Appl Physiol (1985) 117:706-719 doi: 10.1152/japplphysiol.00454.2014 PMID: 25103975
54. Yang R, Sikka G, Larson J, Watts VL, Niu X, Ellis CL et al. (2011) Restoring leptin signaling reduces hyperlipidemia and improves vascular stiffness induced by chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol 300: 1467-1476 doi: 10.1152/ajpheart.00604.2009 PMID: 21278136
55. Epstein LJ, Jervis OJ Jr., Henderson JH 2nd, Sullivan M, Mohsenifar Z (2001) Measurement of gastric p(co2) as an index of tissue hypoxia during obstructive sleep apnea. Respiration 68: 28-34 PMID: 11223727
56. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC (1976) Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. Ann Intern Med 85: 714-719 PMID: 999107
57. Kanagy NL, Walker BR, Nelin LD (2001) Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension. 37: 511-515 PMID: 11230327
58. Duennwald T, Gatterer H, Groop PH, Burtscher M, Bernardi L (2013) Effects of a single bout of interval hypoxia on cardiorespiratory control and blood glucose in patients with type 2 diabetes. Diabetes Care 36: 2183-2189 doi: 10.2337/dc12-2113 PMID: 23536585
59. Lyamina NP, Lyamina SV, Senchiknin VN, Mallet RT, Downey HF, Manukhina EB (2011) Normobaric hypoxia conditioning reduces blood pressure and normalizes nitric oxide synthesis in patients with arterial hypertension. J Hypertens 29: 2265-2272 doi: 10.1097/HJH.0b013e32834b5846 PMID: 21897291